Rosuvastain Calcium Tablet, Film Coated
Product Images NDC 62135-693

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastain Calcium (NDC 62135-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Rosuvastatin Tabs 10mg Bottle Label)

Rosuvastatin 10 mg film-coated tablets in a 90-tablet package, labeled by Chartwell RX, LLC. The label includes the NDC 62135-691-90 and indicates the tablets are USP equivalent for rosuvastatin calcium. It also contains a warning to keep out of reach of children and provides storage instructions. The packaging displays a barcode and a note of 'No Varnish'.*

FDA Label Image

Image Description (Rosuvastatin Tabs 20mg Bottle Label)

Label for Rosuvastatin Tablets USP, 20 mg strength, film-coated oral tablets. The package contains 90 tablets and is labeled Rx Only. The product is dispensed by Chartwell RX, LLC. The label includes dosage strength, NDC number 62135-692-90, storage instructions, and warning to keep out of reach of children.*

FDA Label Image

Image Description (Rosuvastatin Tabs 40mg Bottle Label)

Label for Rosuvastatin Calcium 40 mg film-coated tablets, USP, by Chartwell RX, LLC. The label shows the product name Rosuvastatin, strength 40 mg, with a quantity of 30 tablets. Instructions note dispensing with a patient package insert. Barcodes and manufacturer details are also visible.*

FDA Label Image

Image Description (Rosuvastatin Tabs 5mg Bottle Label)

Rosuvastatin Calcium 5 mg film-coated tablets packaging label by Chartwell RX, LLC. The label states 90 tablets per package, includes dosage form as USP tablets, and provides pharmacy dispensing instructions. The label includes NDC 62135-690-90 and a barcode.*

FDA Label Image

Image Description (Rosuvastatin Tabs Graph 1)

A Kaplan-Meier cumulative incidence curve comparing placebo versus Rosuvastatin treatment over a five-year period. The graph includes hazard ratio (HR 0.56 with 95% CI 0.46-0.69) and p-value (<0.001). Below the x-axis, a risk table shows the number of patients at risk at various time points for both the Rosuvastatin and placebo groups.*

FDA Label Image

Image Description (Rosuvastatin Tabs Graph 2)

A forest plot chart showing the hazard ratios and 95% confidence intervals comparing Rosuvastatin 20 mg to Placebo 20 mg for multiple cardiovascular endpoints. Endpoints include primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, with corresponding event counts, hazard ratios, and p-values.*

FDA Label Image

Image Description (Rosuvastatin Tabs Graph 3)

A box plot chart comparing percent change from baseline in LDL-C levels for four statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, across various dosages (mg). The vertical axis represents percent change, while the horizontal axis shows doses for each drug. The chart illustrates LDL-C reduction at different dose levels for each medication.*

FDA Label Image

Image Description (Rosuvastatin Tabs Structure)

Chemical structure of Rosuvastatin Calcium illustrated, showing its molecular components including fluorophenyl group, pyrimidine ring, sulfonamide and calcium ion coordination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.